Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.27 trillion, total revenue of $4.58 trillion and a weighted average PE ratio of 41.66.
Market Cap
8.27T
Revenue
4.58T
Profits
198.58B
PE Ratio
41.66
Profit Margin
4.34%
Dividend Yield
0.42%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 880.19B | -0.18% | 3,920,877 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 540.71B | -0.41% | 7,981,523 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 362.65B | -0.52% | 7,289,641 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 333.54B | 0.94% | 6,695,495 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 286.15B | 2.03% | 1,953,706 | 60.44B |
| 6 | NVS | Novartis AG | 283.17B | 1.97% | 1,115,300 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 280.47B | 0.36% | 7,255,842 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 204.28B | 1.98% | 30,894,957 | 50.57B |
| 9 | AMGN | Amgen Inc. | 178.70B | 0.46% | 2,874,629 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 175.76B | 1.33% | 1,861,540 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 169.18B | 2.11% | 6,351,161 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 159.99B | 0.08% | 1,982,618 | 10.58B |
| 13 | PFE | Pfizer Inc. | 151.21B | 0.30% | 40,354,249 | 63.32B |
| 14 | ABT | Abbott Laboratories | 150.32B | -1.00% | 12,456,256 | 45.13B |
| 15 | DHR | Danaher Corporation | 123.80B | 0.17% | 5,983,291 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 115.56B | -0.63% | 10,439,381 | 48.48B |
| 17 | SYK | Stryker Corporation | 111.96B | -0.99% | 3,033,349 | 25.27B |
| 18 | CVS | CVS Health Corporation | 111.32B | 7.65% | 15,186,004 | 405.67B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 108.54B | 0.78% | 1,202,109 | 12.22B |
| 20 | SNY | Sanofi | 105.28B | 0.95% | 1,770,040 | 54.60B |
| 21 | GSK | GSK plc | 101.79B | 0.30% | 3,897,566 | 43.29B |
| 22 | MDT | Medtronic plc | 99.63B | -0.24% | 11,477,044 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 95.27B | 0.15% | 1,091,965 | 76.39B |
| 24 | MCK | McKesson Corporation | 91.09B | -7.16% | 2,877,028 | 397.96B |
| 25 | BSX | Boston Scientific Corporation | 83.24B | 0.04% | 18,680,076 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 81.37B | 1.53% | 1,177,611 | 200.42B |
| 27 | CI | The Cigna Group | 74.59B | 2.29% | 2,579,180 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 73.36B | 2.67% | 739,849 | 14.92B |
| 29 | MDLN | Medline Inc. | 55.19B | -7.30% | 18,289,485 | 29.14B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 52.81B | 1.03% | 3,384,183 | 28.48B |
| 31 | ARGX | argenx SE | 50.31B | 1.62% | 433,242 | 4.24B |
| 32 | COR | Cencora, Inc. | 49.17B | -17.38% | 7,858,314 | 328.68B |
| 33 | EW | Edwards Lifesciences Corporation | 47.97B | 0.35% | 5,083,737 | 6.30B |
| 34 | ZTS | Zoetis Inc. | 46.77B | -1.17% | 5,274,437 | 9.47B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.69B | 2.89% | 665,108 | 4.45B |
| 36 | CAH | Cardinal Health, Inc. | 44.85B | -2.80% | 4,429,337 | 250.74B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 42.32B | 1.34% | 6,915,047 | 17.35B |
| 38 | BDX | Becton, Dickinson and Company | 41.22B | 0.41% | 3,454,612 | 21.92B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.45B | 0.63% | 1,012,328 | 4.29B |
| 40 | HLN | Haleon plc | 40.42B | 0.65% | 9,921,233 | 14.85B |
| 41 | ONC | BeOne Medicines AG | 34.83B | 5.32% | 386,037 | 5.74B |
| 42 | WAT | Waters Corporation | 34.31B | 1.98% | 1,864,885 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 33.26B | 0.14% | 2,734,584 | 7.07B |
| 44 | ALC | Alcon Inc. | 32.43B | -11.87% | 6,909,300 | 10.40B |
| 45 | RVMD | Revolution Medicines, Inc. | 32.12B | 2.62% | 2,946,213 | - |
| 46 | NTRA | Natera, Inc. | 30.71B | 4.02% | 2,136,286 | 2.31B |
| 47 | RMD | ResMed Inc. | 30.41B | 0.85% | 1,455,626 | 5.54B |
| 48 | RPRX | Royalty Pharma plc | 30.07B | 0.56% | 3,888,103 | 2.44B |
| 49 | INSM | Insmed Incorporated | 29.59B | -1.69% | 2,301,729 | 606.42M |
| 50 | HUM | Humana Inc. | 29.57B | 2.84% | 1,544,854 | 137.20B |
| 51 | IQV | IQVIA Holdings Inc. | 29.45B | 0.03% | 1,837,295 | 16.63B |
| 52 | BIIB | Biogen Inc. | 28.15B | 0.82% | 741,347 | 9.94B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.08B | 1.14% | 5,358,094 | 20.98B |
| 54 | VEEV | Veeva Systems Inc. | 27.33B | -2.24% | 35,855,709 | 3.20B |
| 55 | CNC | Centene Corporation | 27.32B | 4.44% | 7,989,121 | 178.33B |
| 56 | MTD | Mettler-Toledo International Inc. | 26.87B | 1.89% | 183,286 | 4.03B |
| 57 | UTHR | United Therapeutics Corporation | 26.15B | 4.29% | 660,200 | 3.17B |
| 58 | PHG | Koninklijke Philips N.V. | 25.90B | 2.95% | 3,327,711 | 20.34B |
| 59 | BNTX | BioNTech SE | 24.09B | -0.25% | 1,038,577 | 3.23B |
| 60 | DXCM | DexCom, Inc. | 23.29B | 1.48% | 5,902,656 | 4.82B |
| 61 | WST | West Pharmaceutical Services, Inc. | 22.08B | 0.83% | 789,202 | 3.22B |
| 62 | ILMN | Illumina, Inc. | 21.57B | 2.52% | 1,331,915 | 4.39B |
| 63 | LH | Labcorp Holdings Inc. | 21.07B | -0.08% | 1,066,263 | 14.14B |
| 64 | STE | STERIS plc | 21.03B | 0.70% | 617,178 | 5.83B |
| 65 | DGX | Quest Diagnostics Incorporated | 20.94B | -0.90% | 898,644 | 11.28B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.63B | 1.77% | 3,689,754 | 13.31M |
| 67 | INCY | Incyte Corporation | 19.95B | 2.44% | 1,178,722 | 5.36B |
| 68 | MRNA | Moderna, Inc. | 19.36B | 4.45% | 4,390,298 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.57B | 2.77% | 22,503,458 | 14.30B |
| 70 | GMAB | Genmab A/S | 17.09B | 1.34% | 1,451,964 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.75B | 4.07% | 2,047,731 | 21.46B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.02B | -0.22% | 2,379,042 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 14.79B | 8.86% | 2,437,274 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.57B | 4.71% | 877,921 | 845.52M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.34B | 7.68% | 2,148,105 | 4.44B |
| 76 | SMMT | Summit Therapeutics Inc. | 13.85B | 1.77% | 3,859,258 | - |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.64B | 1.17% | 59,386 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.33B | -1.00% | 2,643,488 | 502.08M |
| 79 | ELAN | Elanco Animal Health Incorporated | 13.07B | 13.88% | 12,365,258 | 4.89B |
| 80 | SNN | Smith & Nephew plc | 12.98B | -3.35% | 3,610,893 | 6.16B |
| 81 | PEN | Penumbra, Inc. | 12.75B | 0.10% | 341,571 | 1.45B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 12.70B | 2.14% | 1,799,711 | 1.06B |
| 83 | ALGN | Align Technology, Inc. | 12.46B | 3.10% | 768,389 | 4.10B |
| 84 | DVA | DaVita Inc. | 12.45B | 23.46% | 2,940,891 | 13.84B |
| 85 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.38B | 7.42% | 569,274 | 1.13B |
| 86 | EXEL | Exelixis, Inc. | 12.37B | 9.64% | 6,340,160 | 2.38B |
| 87 | SOLV | Solventum Corporation | 12.29B | 2.82% | 2,686,836 | 8.26B |
| 88 | MEDP | Medpace Holdings, Inc. | 12.19B | -0.82% | 356,389 | 2.68B |
| 89 | GMED | Globus Medical, Inc. | 12.10B | -0.90% | 1,368,913 | 2.94B |
| 90 | GH | Guardant Health, Inc. | 12.10B | 3.05% | 1,682,802 | 982.02M |
| 91 | COO | The Cooper Companies, Inc. | 11.93B | -0.21% | 3,333,032 | 4.15B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.56B | 1.51% | 4,338,547 | 3.85B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 11.46B | -0.19% | 559,793 | 708.24M |
| 94 | FMS | Fresenius Medical Care AG | 11.32B | 4.06% | 1,304,999 | 22.32B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.08B | 5.62% | 1,672,351 | 1.09B |
| 96 | RVTY | Revvity, Inc. | 11.08B | 7.36% | 3,014,200 | 2.90B |
| 97 | BTSG | BrightSpring Health Services, Inc. | 10.85B | 2.53% | 2,214,372 | 13.65B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 2.55% | 2,359,515 | 3.24B |
| 99 | PODD | Insulet Corporation | 10.48B | -9.70% | 4,461,184 | 2.90B |
| 100 | EHC | Encompass Health Corporation | 10.42B | -0.14% | 1,047,033 | 6.07B |
| 101 | MOH | Molina Healthcare, Inc. | 10.28B | 2.74% | 784,443 | 43.10B |
| 102 | UHS | Universal Health Services, Inc. | 10.28B | 1.87% | 1,108,167 | 17.76B |
| 103 | ABVX | ABIVAX Société Anonyme | 10.26B | 2.23% | 1,239,846 | 5.37M |
| 104 | ENSG | The Ensign Group, Inc. | 10.20B | -0.01% | 653,447 | 5.27B |
| 105 | TEM | Tempus AI, Inc. | 9.61B | -1.05% | 10,691,712 | 1.36B |
| 106 | ICLR | ICON Public Limited Company | 9.47B | 2.21% | 1,230,808 | 8.10B |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 9.42B | 1.43% | 361,057 | 7.46M |
| 108 | MASI | Masimo Corporation | 9.35B | -0.05% | 1,019,003 | 1.56B |
| 109 | CYTK | Cytokinetics, Incorporated | 9.31B | -2.92% | 4,803,286 | 105.82M |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.97B | -1.97% | 1,102,516 | 4.02B |
| 111 | BAX | Baxter International Inc. | 8.77B | 1.37% | 5,871,303 | 11.32B |
| 112 | IBRX | ImmunityBio, Inc. | 8.65B | 10.55% | 19,637,732 | 113.29M |
| 113 | KRYS | Krystal Biotech, Inc. | 8.52B | 1.55% | 288,687 | 417.30M |
| 114 | HSIC | Henry Schein, Inc. | 8.25B | -2.60% | 2,495,457 | 13.38B |
| 115 | PCVX | Vaxcyte, Inc. | 8.24B | 2.62% | 1,600,525 | - |
| 116 | NUVL | Nuvalent, Inc. | 8.19B | 2.66% | 479,277 | - |
| 117 | GKOS | Glaukos Corporation | 7.94B | 1.39% | 889,289 | 551.35M |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.86B | 0.73% | 1,029,352 | 1.40B |
| 119 | ATR | AptarGroup, Inc. | 7.83B | 0.89% | 940,800 | 3.87B |
| 120 | TECH | Bio-Techne Corporation | 7.42B | -16.36% | 11,945,865 | 1.21B |
| 121 | QGEN | Qiagen N.V. | 7.12B | 1.29% | 1,643,978 | 2.09B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.10B | 4.29% | 426,842 | 51.48M |
| 123 | RGEN | Repligen Corporation | 7.09B | 0.12% | 1,625,340 | 763.34M |
| 124 | HQY | HealthEquity, Inc. | 7.03B | 0.75% | 788,379 | 1.31B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 6.93B | 0.74% | 498,479 | 2.59B |
| 126 | CELC | Celcuity Inc. | 6.74B | -1.59% | 801,527 | - |
| 127 | MIRM | Mirum Pharmaceuticals, Inc. | 6.71B | 4.04% | 1,005,731 | 569.61M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.69B | 4.80% | 989,855 | 74.06M |
| 129 | GRFS | Grifols, S.A. | 6.67B | 1.57% | 354,244 | 8.83B |
| 130 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.62B | 4.66% | 1,244,793 | 217.17M |
| 131 | BRKR | Bruker Corporation | 6.44B | 11.29% | 3,145,915 | 3.46B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.34B | 2.80% | 711,393 | - |
| 133 | APGE | Apogee Therapeutics, Inc. | 6.32B | 1.50% | 413,676 | - |
| 134 | HIMS | Hims & Hers Health, Inc. | 6.21B | 2.09% | 14,901,223 | 2.35B |
| 135 | TGTX | TG Therapeutics, Inc. | 6.20B | 16.26% | 6,589,141 | 700.35M |
| 136 | BLTE | Belite Bio, Inc | 6.15B | 1.19% | 173,941 | - |
| 137 | COGT | Cogent Biosciences, Inc. | 6.13B | -3.00% | 1,613,354 | - |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.18% | 874,074 | 15.00M |
| 139 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | - | - | - |
| 140 | CGON | CG Oncology, Inc. | 5.99B | 1.24% | 473,290 | 4.04M |
| 141 | OSCR | Oscar Health, Inc. | 5.97B | 10.59% | 18,982,275 | 13.30B |
| 142 | ALKS | Alkermes plc | 5.88B | -2.57% | 2,960,738 | 1.56B |
| 143 | IMVT | Immunovant, Inc. | 5.84B | 2.98% | 1,252,159 | - |
| 144 | AVTR | Avantor, Inc. | 5.76B | 4.72% | 8,256,495 | 6.55B |
| 145 | BLCO | Bausch + Lomb Corporation | 5.70B | - | 446,105 | 5.10B |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 5.66B | 1.52% | 724,087 | 7.50M |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.62B | -0.06% | 921,066 | - |
| 148 | CHE | Chemed Corporation | 5.61B | -0.70% | 216,761 | 2.54B |
| 149 | CORT | Corcept Therapeutics Incorporated | 5.60B | 1.60% | 1,534,456 | 769.10M |
| 150 | LNTH | Lantheus Holdings, Inc. | 5.60B | 0.38% | 1,079,802 | 1.54B |
| 151 | PTCT | PTC Therapeutics, Inc. | 5.52B | 2.35% | 637,932 | 1.73B |
| 152 | TFX | Teleflex Incorporated | 5.45B | 2.10% | 964,095 | 1.99B |
| 153 | CAI | Caris Life Sciences, Inc. | 5.41B | 0.95% | 1,671,447 | 812.03M |
| 154 | LEGN | Legend Biotech Corporation | 5.36B | 1.58% | 3,469,200 | 1.03B |
| 155 | PACS | PACS Group, Inc. | 5.32B | 3.80% | 386,673 | 5.29B |
| 156 | CRSP | CRISPR Therapeutics AG | 5.31B | 5.15% | 2,529,832 | 4.10M |
| 157 | APLS | Apellis Pharmaceuticals, Inc. | 5.26B | 0.37% | 3,719,948 | 1.00B |
| 158 | STVN | Stevanato Group S.p.A. | 5.19B | 4.34% | 516,106 | 1.39B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.94B | 0.20% | 466,904 | 1.34M |
| 160 | DOCS | Doximity, Inc. | 4.75B | -0.31% | 2,638,798 | 637.78M |
| 161 | LGND | Ligand Pharmaceuticals Incorporated | 4.66B | 0.11% | 185,387 | 268.09M |
| 162 | RDNT | RadNet, Inc. | 4.59B | -0.64% | 711,847 | 2.04B |
| 163 | MANE | Veradermics, Incorporated | 4.52B | -4.38% | 901,620 | - |
| 164 | SHC | Sotera Health Company | 4.51B | 3.07% | 4,404,922 | 1.19B |
| 165 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.48B | 2.63% | 856,774 | 754.05M |
| 166 | NVST | Envista Holdings Corporation | 4.41B | 3.36% | 4,939,241 | 2.81B |
| 167 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.37B | 2.36% | 1,341,368 | 7.70M |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.34B | 1.57% | 1,302,657 | 3.02B |
| 169 | HNGE | Hinge Health, Inc. | 4.24B | 10.23% | 5,102,246 | 646.34M |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.18B | 1.22% | 1,893,047 | - |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.16B | -0.09% | 2,389,914 | 536.20M |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 3.98B | -2.68% | 2,825,917 | - |
| 173 | IRTC | iRhythm Holdings, Inc. | 3.87B | -0.35% | 562,359 | 787.85M |
| 174 | WAY | Waystar Holding Corp. | 3.82B | -3.49% | 2,468,744 | 1.16B |
| 175 | ALHC | Alignment Healthcare, Inc. | 3.75B | -0.87% | 4,053,278 | 4.26B |
| 176 | VKTX | Viking Therapeutics, Inc. | 3.75B | 3.10% | 2,287,891 | - |
| 177 | LQDA | Liquidia Corporation | 3.75B | 5.01% | 970,046 | 158.32M |
| 178 | BLLN | BillionToOne, Inc. | 3.74B | 1.88% | 716,738 | 305.11M |
| 179 | TLX | Telix Pharmaceuticals Limited | 3.73B | 0.63% | 87,565 | 803.79M |
| 180 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.73B | -1.10% | 1,815,441 | 588.99M |
| 181 | TWST | Twist Bioscience Corporation | 3.71B | 4.99% | 1,446,195 | 409.48M |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.68B | -3.89% | 3,577,886 | 1.10B |
| 183 | MMSI | Merit Medical Systems, Inc. | 3.68B | 1.97% | 1,111,571 | 1.54B |
| 184 | LIVN | LivaNova PLC | 3.62B | 15.05% | 1,932,804 | 1.43B |
| 185 | NAMS | NewAmsterdam Pharma Company N.V. | 3.56B | 3.82% | 1,053,583 | 22.50M |
| 186 | OGN | Organon & Co. | 3.52B | 0.45% | 8,263,349 | 6.16B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.41B | -2.40% | 1,475,612 | 62.38M |
| 188 | ERAS | Erasca, Inc. | 3.39B | 9.11% | 6,044,292 | - |
| 189 | BKD | Brookdale Senior Living Inc. | 3.37B | 1.07% | 3,586,656 | 3.05B |
| 190 | MMED | MiniMed Group, Inc. | 3.31B | 0.94% | 439,190 | 2.99B |
| 191 | VCYT | Veracyte, Inc. | 3.29B | 24.93% | 2,994,306 | 541.74M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.27B | -0.23% | 1,825,430 | 236.00M |
| 193 | ALMS | Alumis Inc. | 3.24B | -2.41% | 560,541 | 24.05M |
| 194 | BEAM | Beam Therapeutics Inc. | 3.24B | 11.90% | 2,187,807 | 139.74M |
| 195 | DNLI | Denali Therapeutics Inc. | 3.24B | 7.88% | 2,199,216 | - |
| 196 | OPCH | Option Care Health, Inc. | 3.21B | -3.99% | 5,502,264 | 5.67B |
| 197 | KLRA | Kailera Therapeutics, Inc. | 3.20B | 1.81% | 531,174 | - |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.11B | 7.84% | 1,720,219 | - |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.02B | 3.20% | 1,383,494 | 415.62M |
| 200 | PRVA | Privia Health Group, Inc. | 3.01B | -1.24% | 1,325,112 | 2.12B |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.99B | 4.74% | 1,922,420 | 776.83M |
| 202 | ICUI | ICU Medical, Inc. | 2.99B | 2.26% | 230,804 | 2.23B |
| 203 | TXG | 10x Genomics, Inc. | 2.93B | 3.32% | 2,801,602 | 642.82M |
| 204 | CON | Concentra Group Holdings Parent, Inc. | 2.93B | - | 505,605 | 2.16B |
| 205 | ITGR | Integer Holdings Corporation | 2.93B | 0.51% | 543,699 | 1.86B |
| 206 | GPCR | Structure Therapeutics Inc. | 2.90B | -0.63% | 867,352 | - |
| 207 | NKTR | Nektar Therapeutics | 2.87B | 1.11% | 568,023 | 55.23M |
| 208 | LFST | LifeStance Health Group, Inc. | 2.85B | 0.27% | 3,739,121 | 1.42B |
| 209 | KOD | Kodiak Sciences Inc. | 2.85B | 7.57% | 387,829 | - |
| 210 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | -0.43% | 940,410 | 451.36M |
| 211 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.04% | 1,956,726 | 190.41M |
| 212 | CLDX | Celldex Therapeutics, Inc. | 2.70B | 1.57% | 534,788 | 1.55M |
| 213 | WRBY | Warby Parker Inc. | 2.70B | 1.71% | 3,069,496 | 871.91M |
| 214 | NHC | National HealthCare Corporation | 2.64B | 1.41% | 111,979 | 1.52B |
| 215 | IMNM | Immunome, Inc. | 2.64B | 0.69% | 786,862 | 6.94M |
| 216 | VERA | Vera Therapeutics, Inc. | 2.62B | 6.01% | 825,092 | - |
| 217 | IRON | Disc Medicine, Inc. | 2.62B | 1.57% | 378,750 | - |
| 218 | HTFL | HeartFlow, Inc. | 2.61B | 1.10% | 587,761 | 176.03M |
| 219 | GRAL | GRAIL, Inc. | 2.58B | 15.35% | 1,255,938 | 156.12M |
| 220 | PBH | Prestige Consumer Healthcare Inc. | 2.57B | -2.58% | 519,183 | 1.10B |
| 221 | DFTX | Definium Therapeutics, Inc. | 2.55B | 4.55% | 1,512,567 | - |
| 222 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 3.68% | 3,454,790 | 670.00M |
| 223 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -0.21% | 898,915 | 225.27M |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.52B | -1.48% | 316,976 | 256.28M |
| 225 | TMDX | TransMedics Group, Inc. | 2.52B | -23.19% | 7,794,556 | 635.89M |
| 226 | ELVN | Enliven Therapeutics, Inc. | 2.51B | -0.91% | 370,282 | - |
| 227 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 2.87% | 1,002,965 | - |
| 228 | RLAY | Relay Therapeutics, Inc. | 2.48B | -0.62% | 3,439,265 | 10.68M |
| 229 | HAE | Haemonetics Corporation | 2.45B | -5.30% | 1,273,780 | 1.32B |
| 230 | SRPT | Sarepta Therapeutics, Inc. | 2.43B | 5.69% | 4,784,413 | 2.18B |
| 231 | PAHC | Phibro Animal Health Corporation | 2.37B | 4.02% | 301,790 | 1.50B |
| 232 | ZLAB | Zai Lab Limited | 2.36B | 0.14% | 1,055,115 | 460.16M |
| 233 | ADMA | ADMA Biologics, Inc. | 2.34B | -1.66% | 12,973,207 | 510.17M |
| 234 | ACHC | Acadia Healthcare Company, Inc. | 2.33B | 0.12% | 2,610,693 | 3.37B |
| 235 | GRDN | Guardian Pharmacy Services, Inc. | 2.32B | -1.77% | 467,380 | 1.46B |
| 236 | HCM | HUTCHMED (China) Limited | 2.32B | 0.98% | 16,443 | 548.51M |
| 237 | AXGN | Axogen, Inc. | 2.31B | -0.59% | 545,045 | 238.11M |
| 238 | ADPT | Adaptive Biotechnologies Corporation | 2.31B | 4.72% | 4,900,340 | 295.41M |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | -2.21% | 9,012,954 | 885.72M |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.23B | -2.02% | 7,956,864 | 3.68B |
| 241 | ESTA | Establishment Labs Holdings Inc. | 2.19B | 5.00% | 2,138,549 | 229.58M |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.11B | - | 3,791,900 | 52.04M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 1.28% | 715,148 | 283.06M |
| 244 | BHC | Bausch Health Companies Inc. | 2.11B | 0.18% | 1,227,154 | 10.53B |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.07B | 0.97% | 575,030 | 184.42M |
| 246 | INBX | Inhibrx Biosciences, Inc. | 2.07B | 10.71% | 774,276 | 1.30M |
| 247 | SEM | Select Medical Holdings Corporation | 2.04B | -0.06% | 956,202 | 5.52B |
| 248 | ZYME | Zymeworks Inc. | 2.04B | 3.49% | 427,416 | 105.97M |
| 249 | TRVI | Trevi Therapeutics, Inc. | 2.02B | -2.73% | 1,729,057 | - |
| 250 | TYRA | Tyra Biosciences, Inc. | 2.01B | -0.38% | 526,260 | - |
| 251 | TSHA | Taysha Gene Therapies, Inc. | 2.01B | 0.58% | 4,137,699 | 7.47M |
| 252 | NEOG | Neogen Corporation | 2.00B | -0.97% | 1,466,246 | 870.56M |
| 253 | OMCL | Omnicell, Inc. | 1.99B | 0.46% | 463,317 | 1.23B |
| 254 | CAPR | Capricor Therapeutics, Inc. | 1.99B | 4.31% | 710,741 | 11.13M |
| 255 | AAPG | Ascentage Pharma Group International | 1.99B | -1.51% | 5,205 | 82.08M |
| 256 | NBTX | Nanobiotix S.A. | 1.98B | 20.39% | 127,916 | 38.27M |
| 257 | PHVS | Pharvaris N.V. | 1.97B | 0.30% | 409,453 | - |
| 258 | MESO | Mesoblast Limited | 1.96B | 0.13% | 221,145 | 65.38M |
| 259 | SION | Sionna Therapeutics, Inc. | 1.95B | 5.66% | 311,286 | - |
| 260 | GENB | Generate Biomedicines, Inc. | 1.95B | -0.78% | 203,338 | 31.89M |
| 261 | ANAB | AnaptysBio, Inc. | 1.94B | -2.77% | 680,937 | 234.60M |
| 262 | NTLA | Intellia Therapeutics, Inc. | 1.94B | 4.06% | 3,808,533 | 67.67M |
| 263 | ANIP | ANI Pharmaceuticals, Inc. | 1.91B | -0.67% | 269,256 | 883.37M |
| 264 | NVCR | NovoCure Limited | 1.91B | 3.87% | 1,511,219 | 674.41M |
| 265 | GLPG | Galapagos NV | 1.91B | 1.43% | 91,758 | 1.31B |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.90B | 1.36% | 748,905 | 868.45M |
| 267 | SGRY | Surgery Partners, Inc. | 1.89B | 2.14% | 4,522,458 | 3.34B |
| 268 | VCEL | Vericel Corporation | 1.87B | -0.08% | 828,579 | 276.26M |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.86B | 0.54% | 274,438 | - |
| 270 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | 2.74% | 1,699,457 | 217.17M |
| 271 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | 1.78% | 17,691,358 | 66.41M |
| 272 | VRDN | Viridian Therapeutics, Inc. | 1.81B | -6.51% | 7,759,327 | 70.92M |
| 273 | MD | Pediatrix Medical Group, Inc. | 1.80B | 6.63% | 1,636,577 | 1.93B |
| 274 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.78B | -2.25% | 1,376,741 | -665.00K |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.77B | 4.13% | 213,297 | - |
| 276 | ADUS | Addus HomeCare Corporation | 1.77B | -1.83% | 319,206 | 1.45B |
| 277 | AHG | Akso Health Group | 1.76B | -6.82% | 169,806 | 14.84M |
| 278 | NUVB | Nuvation Bio Inc. | 1.75B | 4.35% | 6,331,680 | 143.05M |
| 279 | ARDX | Ardelyx, Inc. | 1.75B | -0.42% | 4,663,168 | 427.68M |
| 280 | OCS | Oculis Holding AG | 1.75B | 6.59% | 263,894 | 1.51M |
| 281 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 1.69% | 977,087 | 71.78M |
| 282 | ASTH | Astrana Health, Inc. | 1.74B | 0.17% | 359,315 | 3.18B |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.73B | -0.32% | 522,649 | 336.39M |
| 284 | PRGO | Perrigo Company plc | 1.69B | 5.33% | 4,414,278 | 4.18B |
| 285 | IOVA | Iovance Biotherapeutics, Inc. | 1.68B | 2.76% | 17,051,722 | 263.50M |
| 286 | AORT | Artivion, Inc. | 1.68B | -3.29% | 516,504 | 441.33M |
| 287 | UFPT | UFP Technologies, Inc. | 1.68B | 2.72% | 467,540 | 608.85M |
| 288 | INVA | Innoviva, Inc. | 1.67B | -0.57% | 617,502 | 420.69M |
| 289 | VIR | Vir Biotechnology, Inc. | 1.66B | 2.80% | 1,592,891 | 68.56M |
| 290 | GLUE | Monte Rosa Therapeutics, Inc. | 1.63B | 5.37% | 1,136,508 | 123.67M |
| 291 | ALMR | Alamar Biosciences, Inc. | 1.63B | -0.25% | 289,568 | 74.21M |
| 292 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | -0.85% | 1,108,597 | 66.05M |
| 293 | IMCR | Immunocore Holdings plc | 1.56B | 6.52% | 330,316 | 412.81M |
| 294 | BCAX | Bicara Therapeutics Inc. | 1.56B | 2.68% | 325,000 | - |
| 295 | PGEN | Precigen, Inc. | 1.56B | 1.62% | 3,739,192 | 9.68M |
| 296 | IMTX | Immatics N.V. | 1.54B | 5.11% | 747,883 | 56.67M |
| 297 | NVAX | Novavax, Inc. | 1.54B | 15.56% | 16,482,983 | 596.34M |
| 298 | ATAI | AtaiBeckley Inc. | 1.53B | 4.25% | 3,940,210 | 4.09M |
| 299 | MBX | MBX Biosciences, Inc. | 1.53B | 8.51% | 465,577 | - |
| 300 | ABCL | AbCellera Biologics Inc. | 1.53B | 8.15% | 7,702,537 | 75.13M |
| 301 | AHCO | AdaptHealth Corp. | 1.52B | -2.81% | 2,346,006 | 3.29B |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.51B | 1.56% | 604,949 | 1.85B |
| 303 | BHVN | Biohaven Ltd. | 1.51B | 3.40% | 2,028,175 | - |
| 304 | HROW | Harrow, Inc. | 1.50B | -0.57% | 712,968 | 272.30M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.49B | -0.72% | 125,350 | - |
| 306 | FTRE | Fortrea Holdings Inc. | 1.48B | 7.64% | 2,868,852 | 2.71B |
| 307 | AVAH | Aveanna Healthcare Holdings Inc. | 1.47B | 4.48% | 2,229,203 | 2.43B |
| 308 | PGNY | Progyny, Inc. | 1.46B | -1.48% | 1,498,489 | 1.29B |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.34% | 325,050 | 2.50M |
| 310 | QURE | uniQure N.V. | 1.44B | 7.84% | 3,552,248 | 18.09M |
| 311 | ENOV | Enovis Corporation | 1.43B | 3.03% | 1,096,485 | 2.25B |
| 312 | ATRC | AtriCure, Inc. | 1.42B | -4.70% | 1,166,271 | 552.16M |
| 313 | PRCT | PROCEPT BioRobotics Corporation | 1.41B | -1.51% | 1,137,062 | 322.02M |
| 314 | CLOV | Clover Health Investments, Corp. | 1.41B | 2.68% | 5,476,162 | 1.92B |
| 315 | WVE | Wave Life Sciences Ltd. | 1.40B | 1.53% | 4,063,402 | 71.80M |
| 316 | GHRS | GH Research PLC | 1.39B | 5.45% | 374,520 | - |
| 317 | STAA | STAAR Surgical Company | 1.37B | 1.09% | 706,602 | 239.44M |
| 318 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.04% | 6,491,189 | 73.62M |
| 319 | ARDT | Ardent Health, Inc. | 1.34B | -7.50% | 547,526 | 6.43B |
| 320 | SVRA | Savara Inc. | 1.34B | 0.38% | 1,000,720 | - |
| 321 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | 3.76% | 561,800 | - |
| 322 | CMPS | COMPASS Pathways plc | 1.32B | 4.72% | 2,466,995 | - |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.32B | -5.28% | 1,922,485 | 915.25M |
| 324 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 4.01% | 267,989 | - |
| 325 | PLSE | Pulse Biosciences, Inc. | 1.31B | 3.00% | 235,826 | 751.00K |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.31B | -0.70% | 398,691 | - |
| 327 | CRVS | Corvus Pharmaceuticals, Inc. | 1.30B | -1.59% | 1,003,174 | - |
| 328 | URGN | UroGen Pharma Ltd. | 1.28B | 10.16% | 2,834,564 | 140.49M |
| 329 | MLTX | MoonLake Immunotherapeutics | 1.27B | 4.06% | 548,891 | - |
| 330 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.51% | 638,153 | - |
| 331 | ZBIO | Zenas BioPharma, Inc. | 1.24B | 0.34% | 352,877 | 10.00M |
| 332 | TNDM | Tandem Diabetes Care, Inc. | 1.24B | -7.16% | 3,131,707 | 1.01B |
| 333 | TDOC | Teladoc Health, Inc. | 1.23B | 2.10% | 4,425,839 | 2.51B |
| 334 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 2.27% | 398,816 | 83.72M |
| 335 | DBVT | DBV Technologies S.A. | 1.20B | 3.13% | 291,310 | 5.74M |
| 336 | BFLY | Butterfly Network, Inc. | 1.19B | -5.60% | 4,879,678 | 102.92M |
| 337 | COLL | Collegium Pharmaceutical, Inc. | 1.18B | 3.37% | 900,917 | 780.57M |
| 338 | NNNN | Anbio Biotechnology | 1.17B | -8.94% | 46,547 | 8.65M |
| 339 | AVLN | Avalyn Pharma Inc. | 1.16B | 1.02% | 673,816 | - |
| 340 | PHAR | Pharming Group N.V. | 1.16B | 1.42% | 4,078 | 376.13M |
| 341 | NEO | NeoGenomics, Inc. | 1.16B | 0.34% | 1,694,851 | 745.97M |
| 342 | AVNS | Avanos Medical, Inc. | 1.16B | 0.08% | 735,807 | 715.90M |
| 343 | EVO | Evotec SE | 1.16B | 1.25% | 139,246 | 925.65M |
| 344 | PNTG | The Pennant Group, Inc. | 1.14B | 3.48% | 465,824 | 1.02B |
| 345 | CNMD | CONMED Corporation | 1.12B | 1.86% | 462,543 | 1.37B |
| 346 | EYPT | EyePoint, Inc. | 1.12B | -2.91% | 1,214,754 | 7.61M |
| 347 | ALVO | Alvotech | 1.12B | 2.00% | 472,940 | 588.90M |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.11B | 2.66% | 265,805 | 773.34M |
| 349 | SEPN | Septerna, Inc. | 1.11B | 2.40% | 308,476 | 45.95M |
| 350 | IVA | Inventiva S.A. | 1.11B | -0.18% | 72,143 | 7.94M |
| 351 | AKTS | Aktis Oncology, Inc. | 1.11B | 3.03% | 163,101 | 6.50M |
| 352 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | 0.04% | 569,405 | - |
| 353 | IRMD | IRADIMED CORPORATION | 1.10B | 0.44% | 64,360 | 86.28M |
| 354 | INNV | InnovAge Holding Corp. | 1.10B | 2.01% | 561,044 | 949.17M |
| 355 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 2.25% | 1,952,069 | 291.85M |
| 356 | MNKD | MannKind Corporation | 1.10B | 24.48% | 36,837,614 | 360.78M |
| 357 | IART | Integra LifeSciences Holdings Corporation | 1.09B | 5.90% | 2,295,331 | 1.64B |
| 358 | CDNA | CareDx, Inc. | 1.08B | 1.21% | 568,705 | 412.82M |
| 359 | ATEC | Alphatec Holdings, Inc. | 1.07B | -31.67% | 21,781,811 | 787.08M |
| 360 | OMER | Omeros Corporation | 1.07B | 0.41% | 539,477 | - |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.06B | 2.14% | 392,762 | 719.89M |
| 362 | BLFS | BioLife Solutions, Inc. | 1.05B | 0.97% | 301,167 | 96.21M |
| 363 | WGS | GeneDx Holdings Corp. | 1.03B | 0.58% | 4,265,235 | 442.68M |
| 364 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.02B | 2.34% | 3,555,410 | 185.74M |
| 365 | GERN | Geron Corporation | 1.01B | -4.24% | 21,462,827 | 196.12M |
| 366 | SANA | Sana Biotechnology, Inc. | 1.01B | 4.30% | 3,566,392 | - |
| 367 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.56% | 909,188 | 204.89M |
| 368 | CRON | Cronos Group Inc. | 994.40M | -0.38% | 983,216 | 146.59M |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 988.01M | 5.79% | 474,970 | 1.02B |
| 370 | SDGR | Schrödinger, Inc. | 969.87M | 0.85% | 2,563,974 | 254.91M |
| 371 | XNCR | Xencor, Inc. | 964.40M | 1.25% | 819,386 | 97.36M |
| 372 | ORIC | ORIC Pharmaceuticals, Inc. | 962.71M | -2.82% | 1,270,790 | - |
| 373 | CERT | Certara, Inc. | 959.81M | 1.29% | 2,149,571 | 418.84M |
| 374 | SLS | SELLAS Life Sciences Group, Inc. | 950.34M | 5.75% | 3,544,640 | - |
| 375 | OMDA | Omada Health, Inc. | 942.33M | 1.34% | 1,005,839 | 260.21M |
| 376 | PCRX | Pacira BioSciences, Inc. | 932.15M | -4.44% | 532,031 | 734.86M |
| 377 | ANNX | Annexon, Inc. | 926.29M | -0.35% | 1,350,933 | - |
| 378 | ABSI | Absci Corporation | 924.91M | 6.06% | 6,849,900 | 2.80M |
| 379 | SPRY | ARS Pharmaceuticals, Inc. | 921.48M | 2.77% | 3,171,217 | 84.28M |
| 380 | CGEM | Cullinan Therapeutics, Inc. | 921.16M | 0.33% | 886,249 | - |
| 381 | LBRX | LB Pharmaceuticals Inc | 917.62M | -2.68% | 218,402 | - |
| 382 | MGTX | MeiraGTx Holdings plc | 916.32M | 1.54% | 494,713 | 81.39M |
| 383 | BVS | Bioventus Inc. | 911.00M | 2.25% | 1,088,260 | 576.30M |
| 384 | DSGN | Design Therapeutics, Inc. | 908.75M | 8.50% | 783,432 | - |
| 385 | CTMX | CytomX Therapeutics, Inc. | 899.08M | 1.23% | 2,626,787 | 76.20M |
| 386 | NUTX | Nutex Health Inc. | 898.63M | 7.93% | 209,270 | 879.95M |
| 387 | JANX | Janux Therapeutics, Inc. | 889.36M | 2.02% | 952,461 | 10.00M |
| 388 | GDRX | GoodRx Holdings, Inc. | 880.42M | 0.39% | 2,008,147 | 796.85M |
| 389 | DRUG | Bright Minds Biosciences Inc. | 874.60M | 3.11% | 144,765 | - |
| 390 | TBPH | Theravance Biopharma, Inc. | 872.29M | 1.26% | 313,013 | 107.46M |
| 391 | ABUS | Arbutus Biopharma Corporation | 870.47M | 0.45% | 1,008,824 | 14.08M |
| 392 | TALK | Talkspace, Inc. | 867.12M | -0.19% | 1,111,734 | 228.87M |
| 393 | VOR | Vor Biopharma Inc. | 861.55M | 2.45% | 626,644 | - |
| 394 | INMD | InMode Ltd. | 861.05M | -5.63% | 1,965,968 | 374.64M |
| 395 | ANRO | Alto Neuroscience, Inc. | 858.44M | -3.77% | 352,797 | - |
| 396 | EVMN | Evommune, Inc. | 858.32M | -1.37% | 521,143 | 13.00M |
| 397 | KURA | Kura Oncology, Inc. | 848.57M | 2.91% | 1,066,103 | 67.48M |
| 398 | SPTX | Seaport Therapeutics, Inc. | 848.45M | - | 498,543 | - |
| 399 | AZTA | Azenta, Inc. | 847.16M | -25.31% | 7,048,428 | 596.48M |
| 400 | OPK | OPKO Health, Inc. | 845.70M | -0.88% | 1,711,235 | 581.12M |
| 401 | SGP | SpyGlass Pharma, Inc. | 838.00M | 2.70% | 150,941 | - |
| 402 | ETON | Eton Pharmaceuticals, Inc. | 824.90M | -0.76% | 493,423 | 79.95M |
| 403 | RLMD | Relmada Therapeutics, Inc. | 824.42M | 6.94% | 833,925 | - |
| 404 | BIOA | BioAge Labs, Inc. | 819.58M | 10.67% | 587,729 | 9.00M |
| 405 | SSII | SS Innovations International, Inc. | 813.76M | 4.36% | 32,147 | 42.48M |
| 406 | ESPR | Esperion Therapeutics, Inc. | 810.83M | 0.96% | 23,773,167 | 403.14M |
| 407 | AMN | AMN Healthcare Services, Inc. | 810.62M | -1.46% | 1,051,861 | 2.73B |
| 408 | ALLO | Allogene Therapeutics, Inc. | 794.59M | 6.45% | 7,352,979 | 22.00K |
| 409 | IRWD | Ironwood Pharmaceuticals, Inc. | 787.57M | 3.43% | 3,764,624 | 296.15M |
| 410 | GYRE | Gyre Therapeutics, Inc. | 779.83M | 3.47% | 131,565 | 116.59M |
| 411 | CBLL | CeriBell, Inc. | 763.51M | -1.03% | 219,039 | 89.06M |
| 412 | CSTL | Castle Biosciences, Inc. | 749.83M | 0.61% | 701,819 | 344.23M |
| 413 | QDEL | QuidelOrtho Corporation | 746.33M | -6.00% | 5,472,822 | 2.66B |
| 414 | SLDB | Solid Biosciences Inc. | 708.58M | 4.35% | 2,262,641 | - |
| 415 | TENX | Tenax Therapeutics, Inc. | 707.72M | -3.76% | 1,077,849 | - |
| 416 | TRAX | First Tracks Biotherapeutics, Inc. | 703.66M | -4.44% | 654,313 | - |
| 417 | EHAB | Enhabit, Inc. | 698.46M | 0.22% | 1,279,236 | 1.06B |
| 418 | TLRY | Tilray Brands, Inc. | 687.07M | 1.23% | 4,405,435 | 858.28M |
| 419 | HSTM | HealthStream, Inc. | 678.42M | -4.97% | 359,879 | 311.78M |
| 420 | LXRX | Lexicon Pharmaceuticals, Inc. | 677.89M | -3.03% | 2,210,354 | 49.80M |
| 421 | DRTS | Alpha Tau Medical Ltd. | 667.99M | 2.71% | 401,703 | - |
| 422 | ACRS | Aclaris Therapeutics, Inc. | 667.59M | 0.63% | 997,143 | 7.83M |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 666.67M | 0.73% | 168,349 | - |
| 424 | ZVRA | Zevra Therapeutics, Inc. | 665.04M | 6.03% | 2,070,930 | 106.47M |
| 425 | BWAY | BrainsWay Ltd. | 663.13M | -0.06% | 143,770 | 52.23M |
| 426 | ARVN | Arvinas, Inc. | 656.24M | -3.30% | 1,142,101 | 262.60M |
| 427 | FBRX | Forte Biosciences, Inc. | 649.90M | -2.71% | 109,002 | - |
| 428 | PSNL | Personalis, Inc. | 635.39M | 9.17% | 3,173,355 | 69.65M |
| 429 | CTKB | Cytek Biosciences, Inc. | 635.04M | 3.35% | 554,229 | 201.49M |
| 430 | ALT | Altimmune, Inc. | 633.09M | 6.54% | 4,096,290 | 41.00K |
| 431 | CRMD | CorMedix Inc. | 631.35M | 4.14% | 1,164,407 | 311.71M |
| 432 | STRO | Sutro Biopharma, Inc. | 624.44M | 0.99% | 149,101 | 102.48M |
| 433 | AVR | Anteris Technologies Global Corp. | 619.22M | 3.23% | 637,292 | 1.91M |
| 434 | NPCE | NeuroPace, Inc. | 615.18M | 6.34% | 381,001 | 99.99M |
| 435 | CABA | Cabaletta Bio, Inc. | 608.18M | -10.12% | 6,736,509 | - |
| 436 | AGMB | AgomAb Therapeutics NV | 607.23M | -1.36% | 149,882 | - |
| 437 | PRME | Prime Medicine, Inc. | 604.06M | 0.59% | 2,698,945 | 4.63M |
| 438 | PRTA | Prothena Corporation plc | 601.85M | -0.13% | 333,855 | 9.68M |
| 439 | CBIO | Crescent Biopharma, Inc. | 600.12M | -0.11% | 269,372 | 11.88M |
| 440 | ENGN | enGene Therapeutics Inc. | 592.86M | 12.17% | 388,687 | - |
| 441 | PROK | ProKidney Corp. | 591.84M | 2.08% | 580,605 | 893.00K |
| 442 | DNA | Ginkgo Bioworks Holdings, Inc. | 586.73M | 3.81% | 1,907,723 | 170.16M |
| 443 | TRDA | Entrada Therapeutics, Inc. | 585.68M | 1.78% | 416,166 | 25.42M |
| 444 | CLYM | Climb Bio, Inc. | 583.73M | 6.72% | 1,334,208 | - |
| 445 | AVTX | Avalo Therapeutics, Inc. | 582.64M | 34.13% | 22,460,461 | 59.00K |
| 446 | PHR | Phreesia, Inc. | 579.07M | -1.24% | 977,658 | 480.59M |
| 447 | SIBN | SI-BONE, Inc. | 574.73M | -4.13% | 912,618 | 200.93M |
| 448 | KYTX | Kyverna Therapeutics, Inc. | 573.22M | 2.82% | 588,035 | - |
| 449 | ANL | Adlai Nortye Ltd. | 570.80M | -4.42% | 242,274 | 5.00M |
| 450 | TCMD | Tactile Systems Technology, Inc. | 570.67M | 5.20% | 482,058 | 343.52M |
| 451 | CADL | Candel Therapeutics, Inc. | 558.87M | -0.52% | 1,831,039 | - |
| 452 | CTNM | Contineum Therapeutics, Inc. | 555.56M | 3.41% | 243,158 | - |
| 453 | IMMX | Immix Biopharma, Inc. | 547.08M | 7.95% | 1,119,746 | - |
| 454 | TECX | Tectonic Therapeutic, Inc. | 546.98M | -1.16% | 215,391 | - |
| 455 | MDXG | MiMedx Group, Inc. | 545.14M | 0.55% | 1,574,320 | 389.42M |
| 456 | EIKN | Eikon Therapeutics, Inc. | 539.76M | -3.02% | 230,424 | - |
| 457 | AURA | Aura Biosciences, Inc. | 532.22M | -6.85% | 1,102,996 | - |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 531.96M | 7.31% | 711,249 | 85.21M |
| 459 | PACB | Pacific Biosciences of California, Inc. | 530.93M | 8.23% | 7,522,721 | 160.01M |
| 460 | VSTM | Verastem, Inc. | 527.94M | 0.84% | 1,895,285 | 30.91M |
| 461 | RGNX | REGENXBIO Inc. | 527.53M | 10.85% | 1,456,168 | 170.44M |
| 462 | AQST | Aquestive Therapeutics, Inc. | 525.72M | 1.20% | 1,628,626 | 44.55M |
| 463 | CERS | Cerus Corporation | 518.96M | - | 2,087,175 | 216.56M |
| 464 | SGMT | Sagimet Biosciences Inc. | 517.48M | 8.55% | 1,582,960 | - |
| 465 | VALN | Valneva SE | 516.63M | 2.27% | 41,552 | 205.07M |
| 466 | VREX | Varex Imaging Corporation | 510.16M | 5.55% | 390,486 | 854.40M |
| 467 | STTK | Shattuck Labs, Inc. | 504.89M | 2.14% | 441,758 | 1.00M |
| 468 | NGNE | Neurogene Inc. | 504.86M | 11.71% | 341,495 | 925.00K |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 470 | UPB | Upstream Bio, Inc. | 500.12M | 0.77% | 409,089 | 2.85M |
| 471 | ASMB | Assembly Biosciences, Inc. | 498.39M | 6.13% | 156,302 | 72.30M |
| 472 | XOMA | XOMA Royalty Corporation | 496.41M | - | 164,148 | 52.15M |
| 473 | OFIX | Orthofix Medical Inc. | 493.55M | -1.85% | 502,765 | 825.37M |
| 474 | RIGL | Rigel Pharmaceuticals, Inc. | 493.45M | -5.06% | 849,528 | 299.77M |
| 475 | OCGN | Ocugen, Inc. | 492.54M | -2.35% | 15,684,856 | 4.47M |
| 476 | ADCT | ADC Therapeutics SA | 490.96M | 2.66% | 2,630,420 | 79.18M |
| 477 | PRLD | Prelude Therapeutics Incorporated | 486.67M | 3.64% | 708,211 | 12.14M |
| 478 | LYEL | Lyell Immunopharma, Inc. | 486.48M | 1.12% | 36,445 | 36.00K |
| 479 | OVID | Ovid Therapeutics Inc. | 481.04M | -1.77% | 2,572,451 | 7.25M |
| 480 | KMDA | Kamada Ltd. | 479.61M | 0.37% | 18,041 | 180.46M |
| 481 | WEAV | Weave Communications, Inc. | 478.19M | -1.64% | 2,028,709 | 248.72M |
| 482 | FULC | Fulcrum Therapeutics, Inc. | 473.76M | 1.28% | 546,662 | 80.00M |
| 483 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.01M | 4.26% | 228,259 | - |
| 484 | EBS | Emergent BioSolutions Inc. | 469.53M | 0.55% | 664,843 | 676.80M |
| 485 | BBNX | Beta Bionics, Inc. | 469.46M | 5.24% | 1,038,353 | 110.24M |
| 486 | AGL | agilon health, inc. | 463.98M | 4.15% | 341,017 | 5.82B |
| 487 | ZURA | Zura Bio Limited | 463.97M | -5.60% | 1,456,364 | - |
| 488 | LXEO | Lexeo Therapeutics, Inc. | 461.56M | 4.45% | 616,863 | - |
| 489 | SRTA | Strata Critical Medical, Inc. | 460.76M | 10.58% | 2,177,767 | 228.58M |
| 490 | ANGO | AngioDynamics, Inc. | 460.59M | 0.82% | 263,977 | 313.73M |
| 491 | AUTL | Autolus Therapeutics plc | 452.44M | 3.66% | 2,173,121 | 75.39M |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 452.15M | 0.89% | 271,151 | - |
| 493 | VNDA | Vanda Pharmaceuticals Inc. | 447.40M | 0.68% | 1,690,209 | 217.78M |
| 494 | CGC | Canopy Growth Corporation | 444.50M | 6.48% | 6,416,628 | 203.04M |
| 495 | ENTA | Enanta Pharmaceuticals, Inc. | 442.25M | 5.25% | 344,924 | 66.98M |
| 496 | KIDS | OrthoPediatrics Corp. | 439.73M | 0.47% | 202,567 | 243.30M |
| 497 | CTEV | Claritev Corporation | 438.15M | 0.38% | 96,269 | 965.41M |
| 498 | EVH | Evolent Health, Inc. | 436.69M | -2.05% | 2,248,547 | 1.88B |
| 499 | CATX | Perspective Therapeutics, Inc. | 435.55M | 4.66% | 1,598,807 | 884.00K |
| 500 | LRMR | Larimar Therapeutics, Inc. | 431.11M | 3.49% | 2,415,134 | - |